EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Phytochemical Compounds as Promising Therapeutics for Intestinal Fibrosis in Inflammatory Bowel Disease: A Critical Review

Aya A Touny, Balaji Venkataraman, Shreesh Ojha iD, Mauro Pessia iD, Veedamali S Subramanian, Shamanth Neralagundi Hariharagowdru, Sandeep B Subramanya iD

Nutrients · 25.10.2024 · 16 (21) · 3633

DOI: 10.3390/nu16213633 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Nutrients, online erschienen am 25.10.2024. Verfasst von Aya A Touny und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain P.O. Box 15551, United Arab Emirates. Hauptthemen laut MEDLINE: Inflammatory Bowel Diseases, Phytochemicals, Fibrosis. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 328 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: College of Medicine and Health Sciences, United Arab EmiratesUniversity, UAEU Program for Advanced Research 2023, ASPIRE.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objective: Intestinal fibrosis, a prominent consequence of inflammatory bowel disease (IBD), presents considerable difficulty owing to the absence of licensed antifibrotic therapies. This review assesses the therapeutic potential of phytochemicals as alternate methods for controlling intestinal fibrosis. Phytochemicals, bioactive molecules originating from plants, exhibit potential antifibrotic, anti-inflammatory, and antioxidant activities, targeting pathways associated with inflammation and fibrosis. Compounds such as Asperuloside, Berberine, and olive phenols have demonstrated potential in preclinical models by regulating critical signaling pathways, including TGF-β/Smad and NFκB, which are integral to advancing fibrosis.

Results

The main findings suggest that these phytochemicals significantly reduce fibrotic markers, collagen deposition, and inflammation in various experimental models of IBD. These phytochemicals may function as supplementary medicines to standard treatments, perhaps enhancing patient outcomes while mitigating the adverse effects of prolonged immunosuppressive usage. Nonetheless, additional clinical trials are necessary to validate their safety, effectiveness, and bioavailability in human subjects.

Conclusions

Therefore, investigating phytochemicals may lead to crucial advances in the formulation of innovative treatment approaches for fibrosis associated with IBD, offering a promising avenue for future therapeutic development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Inflammatory Bowel DiseasesPhytochemicalsFibrosisHumansAnimalsAnti-Inflammatory AgentsIntestinesSignal TransductionAntioxidants

Stichwörter der Autor:innen

IBDTGF-betaintestinal fibrosisphytochemicals and healthpolyphenols

Substanzen

PhytochemicalsAnti-Inflammatory AgentsAntioxidants

Autor:innen und Institutionen

  • Department of Physiology, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain P.O. Box 15551, United Arab Emirates.
  • Department of Clinical Pharmacy and Pharmacy Practice, Faculty of Pharmacy, Ahram Canadian University, Giza 12581, Egypt.
  • Department of Pharmacology and Therapeutics, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain P.O. Box 15551, United Arab Emirates.
  • Department of Medicine, University of California, Irvine, CA 92697, USA.
  • Zayed Bin Sultan Center for Health Sciences, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain P.O. Box 15551, United Arab Emirates.

ORCID-Profile: Shreesh Ojha, Mauro Pessia, Sandeep B Subramanya

Förderung

  • College of Medicine and Health Sciences, United Arab EmiratesUniversity
  • UAEU Program for Advanced Research 2023
  • ASPIRE

Zitieren

APA

Touny, A. A., Venkataraman, B., Ojha, S., Pessia, M., Subramanian, V. S., Hariharagowdru, S. N., & Subramanya, S. B. (2024). Phytochemical Compounds as Promising Therapeutics for Intestinal Fibrosis in Inflammatory Bowel Disease: A Critical Review. Nutrients, 16(21), 3633. https://doi.org/10.3390/nu16213633

Vancouver

Touny AA, Venkataraman B, Ojha S, Pessia M, Subramanian VS, Hariharagowdru SN, et al. Phytochemical Compounds as Promising Therapeutics for Intestinal Fibrosis in Inflammatory Bowel Disease: A Critical Review. Nutrients. 2024;16(21):3633. doi:10.3390/nu16213633

BibTeX
@article{Touny2024,
  author = {Touny, Aya A and Venkataraman, Balaji and Ojha, Shreesh and Pessia, Mauro and Subramanian, Veedamali S and Hariharagowdru, Shamanth Neralagundi and Subramanya, Sandeep B},
  title = {Phytochemical Compounds as Promising Therapeutics for Intestinal Fibrosis in Inflammatory Bowel Disease: A Critical Review},
  journal = {Nutrients},
  year = {2024},
  volume = {16},
  number = {21},
  pages = {3633},
  doi = {10.3390/nu16213633}
}
Kostenlos starten →